Listen to our latest Investing Matters Podcast episode 'Uncovering opportunities with investment trusts' with The AIC's Richard Stone here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
CERN, CHUV AND THERYQ JOIN FORCES FOR A
WORLD FIRST IN CANCER RADIOTHERAPY
CERN, the Lausanne University Hospital (CHUV) in Switzerland,
and THERYQ (ALCEN Group, France) signed an agreement
for the world-first development of a revolutionary FLASH
radiotherapy device that will use very high energy electron
(VHEE) radiation to treat cancers resistant to conventional
treatments.
The device will include a compact linear accelerator based on
CERN technology, and will use very high-energy electron beams
of 100 to 200 MeV, allowing cancers up to a depth of 20 cm to
be treated using the FLASH technique. It has the potential to
decrease the overall cost of treatment, and its compactness will
allow it to be used in a hospital setting. It will be based at CHUV
and is expected to be operational within two years, with the first
clinical trials planned for 2025.
Basil,
Electron beam therapy and proton beam therapy are distinct modalities used in radiation treatment. Proton beam therapy is particularly known for utilizing the Bragg Peak effect, which allows for maximum energy delivery at a controlled depth, minimizing damage to surrounding tissues. Just Google.
FLASH (Fast Linear Accelerator System for Hadrons) therapy is an innovative approach that delivers an ultra-high dose of radiation in a single pulse. This technique can be applied using both electrons and protons, and is designed to maximize the therapeutic effect while minimizing damage to healthy tissue. The LIGHT system developed by AVO is an example of technology that can deliver FLASH therapy.
A LINAC refers to a Linear Accelerator, which is used to accelerate particles along a straight path, as opposed to circular accelerators like cyclotrons or synchrotrons. LINACs are versatile and can be used to accelerate various types of particles, including electrons and protons. AVO's innovation lies in adapting LINAC technology for proton therapy, which offers several benefits. These include the ability to rapidly adjust beam energies without loss of intensity, which is crucial for targeting tumors at varying depths with precision. Moreover, linear accelerators for protons can be more cost-effective compared to traditional circular accelerators.
So, the CHUV plan is technically not comparable with what AVO has in the pipeline. But if AVO would be able to deliver, I'm sure the CHUV would think about to use this much better technology.
Lost chance.
Thank you for your informative reply. I knew we were not involved as we had not been rns'd but was fishing for an explanation. Thank you for your knowledgeable insight